BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19711376)

  • 1. Lectin-based glycoproteomics to explore and analyze hepatocellular carcinoma-related glycoprotein markers.
    Dai Z; Zhou J; Qiu SJ; Liu YK; Fan J
    Electrophoresis; 2009 Sep; 30(17):2957-2966. PubMed ID: 19711376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.
    Zhu J; Warner E; Parikh ND; Lubman DM
    Mass Spectrom Rev; 2019 May; 38(3):265-290. PubMed ID: 30472795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of serum Haptoglobin using glycoproteomics and lectin immunoassay in liver diseases in Hepatitis B virus infection.
    Dalal K; Dalal B; Bhatia S; Shukla A; Shankarkumar A
    Clin Chim Acta; 2019 Aug; 495():309-317. PubMed ID: 31014754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and application of a novel recombinant Aleuria aurantia lectin with enhanced core fucose binding for identification of glycoprotein biomarkers of hepatocellular carcinoma.
    Norton P; Comunale MA; Herrera H; Wang M; Houser J; Wimmerova M; Romano PR; Mehta A
    Proteomics; 2016 Dec; 16(24):3126-3136. PubMed ID: 27650323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and analysis of altered alpha1,6-fucosylated glycoproteins associated with hepatocellular carcinoma metastasis.
    Dai Z; Liu YK; Cui JF; Shen HL; Chen J; Sun RX; Zhang Y; Zhou XW; Yang PY; Tang ZY
    Proteomics; 2006 Nov; 6(21):5857-67. PubMed ID: 17068759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface glycoproteomic analysis of hepatocellular carcinoma cells by affinity enrichment and mass spectrometric identification.
    Mi W; Jia W; Zheng Z; Wang J; Cai Y; Ying W; Qian X
    Glycoconj J; 2012 Aug; 29(5-6):411-24. PubMed ID: 22752401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifucosylated Alpha-1-acid Glycoprotein as a Novel Marker for Hepatocellular Carcinoma.
    Tanabe K; Kitagawa K; Kojima N; Iijima S
    J Proteome Res; 2016 Sep; 15(9):2935-44. PubMed ID: 27354006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycomic analysis of alpha-fetoprotein L3 in hepatoma cell lines and hepatocellular carcinoma patients.
    Nakagawa T; Miyoshi E; Yakushijin T; Hiramatsu N; Igura T; Hayashi N; Taniguchi N; Kondo A
    J Proteome Res; 2008 Jun; 7(6):2222-33. PubMed ID: 18479159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered glycosylation associated with dedifferentiation of hepatocellular carcinoma: a lectin microarray-based study.
    Takayama H; Ohta M; Iwashita Y; Uchida H; Shitomi Y; Yada K; Inomata M
    BMC Cancer; 2020 Mar; 20(1):192. PubMed ID: 32143591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of fucosylation in liver-secreted N-glycoproteins from human hepatocellular carcinoma plasma using liquid chromatography with tandem mass spectrometry.
    Ji ES; Hwang H; Park GW; Lee JY; Lee HK; Choi NY; Jeong HK; Kim KH; Kim JY; Lee S; Ahn YH; Yoo JS
    Anal Bioanal Chem; 2016 Nov; 408(27):7761-7774. PubMed ID: 27565792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation change of alpha-1-acid glycoprotein as a serum biomarker for hepatocellular carcinoma and cirrhosis.
    Zhang D; Huang J; Luo D; Feng X; Liu Y; Liu Y
    Biomark Med; 2017 May; 11(5):423-430. PubMed ID: 28621608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans.
    Block TM; Comunale MA; Lowman M; Steel LF; Romano PR; Fimmel C; Tennant BC; London WT; Evans AA; Blumberg BS; Dwek RA; Mattu TS; Mehta AS
    Proc Natl Acad Sci U S A; 2005 Jan; 102(3):779-84. PubMed ID: 15642945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective isolation and analysis of glycoprotein fractions and their glycomes from hepatocellular carcinoma sera.
    Yang G; Cui T; Wang Y; Sun S; Ma T; Wang T; Chen Q; Li Z
    Proteomics; 2013 May; 13(9):1481-98. PubMed ID: 23436760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of N-glycosylation sites on secreted proteins of human hepatocellular carcinoma cells with a complementary proteomics approach.
    Cao J; Shen C; Wang H; Shen H; Chen Y; Nie A; Yan G; Lu H; Liu Y; Yang P
    J Proteome Res; 2009 Feb; 8(2):662-72. PubMed ID: 19196183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of a Vicia unijuga lectin-binding (Vgu) glycoprotein with Thomsen-Friedenreich (T) activity and Vgu glycoproteins in human primary hepatocellular carcinoma.
    Otsuka K; Mizuno M; Kagawa K; Kashima K; Ohkuma S
    Int J Biochem; 1992 Sep; 24(9):1407-19. PubMed ID: 1330763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry analysis of glycoprotein biomarkers in human blood of hepatocellular carcinoma.
    Kim KH; Kim JY; Yoo JS
    Expert Rev Proteomics; 2019 Jul; 16(7):553-568. PubMed ID: 31145639
    [No Abstract]   [Full Text] [Related]  

  • 17. Lectin-based glycoproteomic techniques for the enrichment and identification of potential biomarkers.
    Abbott KL; Pierce JM
    Methods Enzymol; 2010; 480():461-76. PubMed ID: 20816222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
    Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
    J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycomic analyses of glycoproteins in bile and serum during rat hepatocarcinogenesis.
    Nakagawa T; Takeishi S; Kameyama A; Yagi H; Yoshioka T; Moriwaki K; Masuda T; Matsumoto H; Kato K; Narimatsu H; Taniguchi N; Miyoshi E
    J Proteome Res; 2010 Oct; 9(10):4888-96. PubMed ID: 20731380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas.
    Yamashita K; Taketa K; Nishi S; Fukushima K; Ohkura T
    Cancer Res; 1993 Jul; 53(13):2970-5. PubMed ID: 7686446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.